Not FDA-approved2,3Evidence: Animal and lab onlyMuscle

PEG-MGF2

Also called Mechano growth factor pegylated, Mechano growth factor1,2

Key takeaway

PEG-MGF is a pegylated form of mechano growth factor (MGF), a synthetic 24-amino-acid peptide matching the end of one form of the insulin-like growth factor 1 precursor; pegylation attaches polyethylene glycol chains to it.1,2 FDA states that it has not identified any human exposure data for PEG-MGF and that it may pose a significant risk of immune reactions. A 2010 review notes that no natural MGF peptide has been found in the body.2,4 No FDA approval is reported in the sources reviewed here, and PEG-MGF is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.2,6

PEG-MGF at a glance

What it isMechano growth factor, a 24-amino-acid peptide also recorded as the IGF-1Ec peptide, with polyethylene glycol attached.1,2
FDA statusNo FDA approval is reported in the sources reviewed here. FDA’s compounding safety-risk page lists PEG-MGF among withdrawn nominations with safety concerns, and FDA lists MGF among substances nominated for compounding without adequate support.2,3
Human evidenceNone. FDA states that it has not identified any human exposure data for products containing PEG-MGF.2
Evidence strengthAnimal and lab studies only. The cited sources report no completed human study; the research base consists of animal, cell, or other laboratory work. How this label is assigned

What is PEG-MGF?

Mechano growth factor (MGF) is a synthetic peptide of 24 amino acids, which FDA’s substance registry also records as the insulin-like growth factor 1-Ec peptide.1

A 2010 review explains that the name comes from a form of the insulin-like growth factor 1 gene message that rises in muscle after stretch or injury, and that the synthetic peptide copies the last 24 amino acids of the protein it would encode.4

PEG-MGF, mechano growth factor pegylated, is MGF with polyethylene glycol attached, according to FDA’s compounding safety-risk page.2

The research literature listed on this page concerns mechano growth factor (MGF) itself. FDA states that it has identified no human exposure data for PEG-MGF, and the 2010 review discusses only the non-pegylated peptide.2,4

How is PEG-MGF thought to work?

In laboratory studies, synthetic MGF promoted the multiplication and survival of cells, including muscle precursor cells, according to the 2010 review.4

The review states that no matching peptide made by the body has been identified in cells, tissues or body fluids, and it distinguishes the actions of synthetic MGF from any known natural product of the gene.4

What do human studies show?

FDA states that it has not identified any human exposure data on products containing PEG-MGF by any route, and that it lacks important information on whether it would cause harm if given to people.2

The sources reviewed here describe only laboratory research on the non-pegylated peptide.4

What the evidence base contains

  • Animal or laboratory research Laboratory studies, summarized in a 2010 review, in which the synthetic MGF peptide promoted the growth and survival of cells.4

Evidence-strength label: Animal and lab studies only. How this label is assigned

Is PEG-MGF FDA-approved?

None of the sources reviewed here reports an approval of PEG-MGF by FDA.1,2

FDA’s compounding safety-risk page, current as of April 22, 2026, lists PEG-MGF among bulk substances previously in category 2, for substances that may present significant safety risks, whose nominations were withdrawn. It cites a possible significant risk of immune reactions and complexities with impurities and characterization.2

FDA’s list of substances nominated for pharmacy compounding, updated May 14, 2026, places mechano growth factor (MGF) in category 3, substances nominated without adequate support.3

HHS’s October 30, 2026 draft enforcement-discretion policy lists six peptides in its Appendix A: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500. PEG-MGF is not among them.5,6

Timeline

  1. A review in Endocrinology notes that no natural MGF peptide has been found in the body.4
  2. FDA’s compounding safety-risk page, as last updated, lists PEG-MGF among withdrawn nominations with safety concerns.2
  3. FDA’s updated 503A category lists keep mechano growth factor in category 3.3

What is still unknown?

Whether it has any effect in people, and whether it is safe: FDA has not identified any human exposure data.2

Whether MGF exists as a natural peptide in the body at all, which the 2010 review describes as unproven.4

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Go deeper

Records, reviews and history

Everything PeptideScanner has collected for PEG-MGF: reviews, official-source readings, registry and literature records, and every change to this profile.

What the trial and literature lists cover. The trials and papers listed for PEG-MGF are a bounded selection, not every registration or paper about PEG-MGF. For the years before PEG-MGF was added, PeptideScanner took at most 25 ClinicalTrials.gov registrations that list PEG-MGF as an intervention: trials with posted results first, then later-phase trials, then the most recently updated. It also took at most 25 PubMed papers that name PEG-MGF in the title: randomized controlled trials, clinical trials, meta-analyses, systematic reviews and reviews first, then the most recent. Records that also named another tracked peptide, or that failed the publication checks, were left out. A daily check adds newly updated registrations and newly indexed papers that pass the same checks. How records are selected.

Status brief and reviewed-evidence summary

Evidence summary

What the cited records show

What is its status in the cited records?

No FDA approval reported; FDA has no human exposure data for it. Evidence is limited to laboratory studies of the non-pegylated peptide, mechano growth factor; the papers listed for this profile concern that peptide. FDA lists PEG-MGF on its compounding safety-risk page among withdrawn nominations. PEG-MGF is not among the six peptides in HHS’s October 2026 draft policy.↗↗↗↗

Status sources checked through November 14, 2026. See status sources and coverage →

Research records

Explore this profile’s cited source records →

An editorial human-evidence summary has not yet been published.

Explore status sources, recent additions, and coverage gaps

Living status brief

What is the current status of PEG-MGF?

No FDA approval reported; FDA has no human exposure data for it. Evidence is limited to laboratory studies of the non-pegylated peptide, mechano growth factor; the papers listed for this profile concern that peptide. FDA lists PEG-MGF on its compounding safety-risk page among withdrawn nominations. PEG-MGF is not among the six peptides in HHS’s October 2026 draft policy.↗↗↗↗

The cited status sources were checked through November 14, 2026. This answer changes only through the profile’s visible version and correction history.

Evidence present

What records are connected here?

Evidence lanes
1
Source years
14
Drugs@FDA applications
0

These are counts in PeptideScanner’s selected public collection, not measures of research quality, medical relevance, safety, or effectiveness.

Collection changes

What did PeptideScanner add most recently?

  1. Literature metadata · added November 16, 2026

    Producing human mechano growth factor (MGF) in Escherichia coli.↗Source date November 9, 2026
  2. Literature metadata · added November 16, 2026

    The role of mechano growth factor in chondrocytes and cartilage defects: a concise review.↗Source date September 21, 2024
  3. Literature metadata · added November 16, 2026

    Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?↗Source date March 21, 2024

Coverage gaps

What remains unknown or unsupported?

PeptideScanner currently has no selected clinical trial records, regulatory records, and safety records connected to this profile. That is a collection gap, not evidence that no such records exist.

PeptideScanner does not infer an answer where the cited records do not provide one. Open the source-linked records below to inspect their scope and limits.

Explore the Evidence Map and record counts

Evidence Map v1

What kinds of records connect to PEG-MGF?

Compare collection coverage →

This map describes PeptideScanner’s selected, source-linked collection. It is not an evidence grade and does not establish research quality, safety, effectiveness, or medical relevance.

20Selected dated records
26Connected citations
14Populated source years2008–2026
1/4Record lanes present

Registered human studies

Trial composition

0 of 0 selected trial records include at least one phase value; 0 of 0 include a status value in the retained structured contract.

PubMed bibliography

Publication composition

20 of 20 selected PubMed records include attributed title, venue, publication date, and publication-type fields.

Publication typesJournal Article 20Research Support, Non-U.S. Gov't 12Review 4English Abstract 1Research Support, N.I.H., Extramural 1Research Support, U.S. Gov't, Non-P.H.S. 1

Regulatory and publication surfaces

What is structurally connected?

Drugs@FDA applications
0
FDA Federal Register documents
0
DailyMed SPL versions
0
Canonical profile
Published
Profile structured data
Published
Linked dated records
20

Application counts reflect exact reviewed ingredient connections; Federal Register counts reflect exact reviewed peptide-name matches; DailyMed counts reflect listed SPL versions with retained ZIP receipts. “Published” describes this page’s indexing surface, not the state of scientific evidence.

Profile publication history and record counts
Source records by collection · 20 dated records

Research hub

Explore the PEG-MGF evidence record

Open all 20 records →
20Dated records
1Evidence type
20Cited public sources
14Source years

Change ledger

Recently changed for PEG-MGF

Open all 20 events →

PeptideScanner change dates and cited source dates stay separate. These entries report collection or version activity, not a ranking of importance.

Record added

[IGF-1 alternative splice isoforms: mechano growth factor].

PubMed lists PMID 16408771 in Sheng li ke xue jin zhan [Progress in physiology] as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Monoclonal antibodies to mechano-growth factor.

PubMed lists PMID 17044786 in Hybridoma (2005) as Journal Article, with publication-date metadata of 2006-10 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 28, 2008
Evidence lane
Literature metadata
Record added

A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor.

PubMed lists PMID 17156777 in Experimental cell research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-11-07 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 19, 2009
Evidence lane
Literature metadata

Official-source collections

Source records for PEG-MGF

Open the full research atlas →

Evidence types

Coverage by source year

Selected records span April 9, 2008 to November 9, 2026. These dates come from selected source records and PubMed metadata, not a complete or continuous timeline of research, safety, approval, or effectiveness.

Continue exploring

Profiles with overlapping source-year coverage

Open the research atlas →

These links are based only on overlapping years and evidence lanes in PeptideScanner’s selected records. They do not imply that the peptides are medically or scientifically similar.

Organizations and trial records named in cited sources

Organizations named in cited records

  • U.S. Food and Drug Administration1,2,3
  • U.S. Department of Health and Human Services5
Dated updates connected to this profile · 20

Updates connected to this profile

Open the full cross-source timeline →
  1. Literature metadata

    Producing human mechano growth factor (MGF) in Escherichia coli.↗

    PubMed lists PMID 18068377 in Protein expression and purification as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-11-07 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    The role of mechano growth factor in chondrocytes and cartilage defects: a concise review.↗

    PubMed lists PMID 37171185 in Acta biochimica et biophysica Sinica as Review, Journal Article, with publication-date metadata of 2023-05-12 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?↗

    PubMed lists PMID 23125840 in Frontiers in endocrinology as Journal Article, with publication-date metadata of 2012-11-01 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration.↗

    PubMed lists PMID 20130113 in Endocrinology as Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2010-02-03 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    [Expression of mechano-growth factor in Escherichia coli and activity analysis].↗

    PubMed lists PMID 18837392 in Sheng wu gong cheng xue bao = Chinese journal of biotechnology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-07 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products.↗

    PubMed lists PMID 22328223 in Rapid communications in mass spectrometry : RCM as Journal Article, with publication-date metadata of 2012-03-30 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles.↗

    PubMed lists PMID 30952709 in Anticancer research as Journal Article, with publication-date metadata of 2019-04 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  8. Literature metadata

    Mechano-growth factor accelerates the proliferation and osteogenic differentiation of rabbit mesenchymal stem cells through the PI3K/AKT pathway.↗

    PubMed lists PMID 25588515 in BMC biochemistry as Journal Article, with publication-date metadata of 2015-01-15 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  9. Literature metadata

    In vitro and in vivo degradation and mechanical properties of ZEK100 magnesium alloy coated with alginate, chitosan and mechano-growth factor.↗

    PubMed lists PMID 27040239 in Materials science & engineering. C, Materials for biological applications as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-02-27 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  10. Literature metadata

    New proangiogenic activity on vascular endothelial cells for C-terminal mechano growth factor.↗

    PubMed lists PMID 22382131 in Acta biochimica et biophysica Sinica as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-03-01 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  11. Literature metadata

    Expression and subcellular localization of mechano-growth factor in osteoblasts under mechanical stretch.↗

    PubMed lists PMID 19911128 in Science in China. Series C, Life sciences as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-11-13 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  12. Literature metadata

    Examination of alternate codon bias solutions for expression and purification of recombinant mechano-growth factor in Escherichia coli.↗

    PubMed lists PMID 25345350 in Biotechnology and applied biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-08-06 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    Mechano growth factor (IGF-1Ec peptide) substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  2. 2
    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  3. 3
    Bulk drug substances nominated for use in compounding under section 503A (categories 1 to 3) · updated May 14, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  4. 4
    Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration (2010) · PMID 20130113 ↗

    Endocrinology · Official source · Source checked November 16, 2026

  5. 5
    Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances · notice of availability · 91 FR 68526 · October 30, 2026 ↗

    Federal Register · U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026

  6. 6
    HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, with Appendix A (list of peptides) and Appendix B (identities and justifications) ↗

    U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026